Differential phosphoinositide 3-kinase signaling: implications for PTCA?
Rocic
Petra
P
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000818:Animals; D020212:Carotid Artery Injuries / Q000201:enzymology* / Q000473:pathology; D049109:Cell Proliferation; D023903:Coronary Restenosis / Q000201:enzymology* / Q000209:etiology / Q000473:pathology; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000201:enzymology* / Q000473:pathology; D004789:Enzyme Activation; D006801:Humans; D006965:Hyperplasia; D009131:Muscle, Smooth, Vascular / Q000201:enzymology* / Q000473:pathology; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D015398:Signal Transduction
D000242:Cyclic AMP; D019869:Phosphatidylinositol 3-Kinases; D017868:Cyclic AMP-Dependent Protein Kinases